VSTM — Verastem Income Statement
0.000.00%
- $75.47m
- $6.38m
Annual income statement for Verastem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.5 | 88.5 | 2.05 | 2.6 | 0 |
Cost of Revenue | |||||
Gross Profit | 16.2 | 55.6 | 2.05 | 2.6 | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 150 | 139 | 63.5 | 75.5 | 92.1 |
Operating Profit | -132 | -50.9 | -61.4 | -72.9 | -92.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -149 | -67.5 | -71.2 | -73.8 | -87.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -149 | -67.7 | -71.2 | -73.8 | -87.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -149 | -67.7 | -71.2 | -73.8 | -87.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -149 | -67.7 | -71.2 | -73.8 | -87.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -24.5 | -4.99 | -4.9 | -4.57 | -3.95 |